0001079973-22-001094.txt : 20220914 0001079973-22-001094.hdr.sgml : 20220914 20220914162520 ACCESSION NUMBER: 0001079973-22-001094 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20220912 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220914 DATE AS OF CHANGE: 20220914 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Marijuana Co of America, Inc. CENTRAL INDEX KEY: 0001078799 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 870426858 STATE OF INCORPORATION: UT FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-27039 FILM NUMBER: 221243254 BUSINESS ADDRESS: STREET 1: 633 W. 5TH STREET STREET 2: SUITE 2826 CITY: LOS ANGELES STATE: CA ZIP: 90071 BUSINESS PHONE: (888) 777-4362 MAIL ADDRESS: STREET 1: 633 W. 5TH STREET STREET 2: SUITE 2826 CITY: LOS ANGELES STATE: CA ZIP: 90071 FORMER COMPANY: FORMER CONFORMED NAME: CONVERGE GLOBAL INC/CA DATE OF NAME CHANGE: 19990806 8-K 1 mcoa_8k-091422.htm FORM 8-K
0001078799 false 0001078799 2022-09-12 2022-09-12 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): September 14, 2022 (September 12, 2022)

 

MARIJUANA COMPANY OF AMERICA, INC.

(Exact Name of Registrant as Specified in Charter) 

 

Utah   000-27039   98-1246221
(State or jurisdiction of   (Commission File   (IRS Employer
incorporation or organization)   Number)   Identification No.) 

  

633 W. 5th Street, Suite 2826

Los Angeles, California ,90071

Telephone: (888) 777-4362

(Address and Telephone Number of Registrant’s Principal
Executive Offices and Principal Place of Business)

 

  

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

    Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425).

 

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12).

 

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).

 

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).

 

Securities registered pursuant to Section 12(b) of the Act: None.

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

  

Securities registered pursuant to Section 12(g) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock    MCOA   None

 

 

 
 

 

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

 

 

Unless otherwise provided in this Current Report on Form 8-K, all references to “we,” “us,” “Company,” “our,” “Marijuana Company of America,” “MCOA,” or the “Registrant” refer to the parent entity, Marijuana Company of America, Inc., a Utah corporation. Unless otherwise indicated in this Current Report on Form 8-K, all references to the Company’s board of directors shall refer to the board of directors of Marijuana Company of America, Inc., a Utah corporation.

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On September 12, 2022, a majority of the stockholders eligible to vote of Marijuana Company of America, Inc. (the “Company”), by written consent pursuant to Utah statute, approved Amendment No. 1 to the Company’s 2017 Equity Incentive Plan (the “2017 Equity Plan Amendment”). The 2017 Equity Plan Amendment had previously been approved by the Company’s Board of Directors (the “Board”), subject to stockholder approval. It became effective as of September 14, 2022.

The 2017 Equity Plan Amendment increases the authorized common shares available for issuance from 500,000,000 to 3,000,000,000, and makes no other material modifications. The full text of the 2017 Equity Plan Amendment attached hereto as Exhibit 10.1 to this Current Report on Form 8-K.

Item 5.07. Submission of Matters to a Vote of Security Holders.

On September 12, 2022, the Company’s 2017 Equity Plan Amendment was approved by a majority of the Company’s stockholders eligible to vote, by written consent pursuant to Utah statute. The 2017 Equity Incentive Plan Amendment had previously been approved by the Board of Directors subject to stockholder approval. It became effective as of September 14, 2022. The full text of the 2017 Equity Plan Amendment attached hereto as Exhibit 10.1 to this Current Report on Form 8-K.

Item 9.01. Financial Statements and Exhibits.

 

Exhibit Number Description
10.1

2017 Equity Incentive Plan Amendment

104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

  

 

 

 
 

SIGNATURES

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

MARIJUANA COMPANY OF AMERICA, INC.

 

   
  By:   /s/ Jesus M. Quintero                        
Date: September 14, 2022

Name: Jesus M. Quintero

Title: Chief Executive Officer

 

 

 

 

 

EX-10.1 2 ex10x1.htm FIRST AMENDMENT TO THE EQUITY INCENTIVE PLAN

Exhibit 10.1

 

 

 

FIRST AMENDMENT TO THE

MARIJUANA COMPANY OF AMERICA, INC. EQUITY INCENTIVE PLAN

WHEREAS, Marijuana Company of America, Inc. (“Company”) previously adopted the Marijuana Company of America, Inc. Equity Incentive Plan (“Plan”); and

WHEREAS, the Company desires to amend the Plan to increase the number of Shares of Common Stock available for issuance thereunder by 2,500,000,000 shares;

WHEREAS, the stockholders of the Company have approved the proposed amendment of the Plan to increase the number of Shares of Common Stock available for issuance thereunder by 2,500,000,000 shares; and

WHEREAS, the Company maintains the right to amend the Plan pursuant to Section 12.2 therein;

NOW THEREFORE, Section 3 of the Plan is deleted in its entirety and replaced with the following, effective September 12, 2022:

 

“4. Shares Subject to the Plan.

 

4.1 Maximum Share Limitations. Subject to appropriate adjustments for stock splits or reverse stock splits, the maximum aggregate number of shares of Common Stock that may be issued and sold under all Awards granted under the Plan shall be up to 3,000,000,000 Shares of Common Stock issued and sold under the Plan may be either authorized but unissued shares or shares held in the Company’s treasury. To the extent that any Award involving the issuance of shares of Common Stock is forfeited, cancelled, returned to the Company for failure to satisfy vesting requirements or other conditions of the Award, or otherwise terminates without an issuance of shares of Common Stock being made thereunder, the shares of Common Stock covered thereby will no longer be counted against the foregoing maximum share limitations and may again be made subject to Awards under the Plan pursuant to such limitations.

 

4.2 Adjustments. If there shall occur any change with respect to the outstanding shares of Common Stock by reason of any recapitalization, reclassification, stock dividend, extraordinary dividend, stock split, reverse stock split or other distribution with respect to the shares of Common Stock, or any merger, reorganization, consolidation, combination, spin-off or other similar corporate change, or any other change affecting the Common Stock, the Committee may, in the manner and to the extent that it deems appropriate and equitable to the Participants and consistent with the terms of the Plan, cause an adjustment to be made in (i) the maximum number and kind of shares provided in Section 4.1 hereof, (ii) the number and kind of shares of Common Stock, or other rights subject to then outstanding Awards, (iii) the exercise or base price for each share or other right subject to then outstanding Awards, and (iv) any other terms of an Award that are affected by the event. Notwithstanding the foregoing, in the case of Incentive Stock Options, any such adjustments shall, to the extent practicable, be made in a manner consistent with the requirements of Section 424(a) of the Code.”

IN WITNESS WHEREOF, this Amendment is hereby executed by a duty authorized officer of the Company this 12th day of September 12, 2022.

 

     
MARIJUANA COMPANY OF AMERICA, INC.
   
By:  

/s/ Jesus Quintero

 
Title: President and CEO


 

 

 

EX-101.SCH 3 mcoa-20220912.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 mcoa-20220912_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 mcoa-20220912_pre.xml XBRL PRESENTATION FILE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.22.2.2
Cover
Sep. 12, 2022
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Sep. 12, 2022
Entity File Number 000-27039
Entity Registrant Name MARIJUANA COMPANY OF AMERICA, INC.
Entity Central Index Key 0001078799
Entity Tax Identification Number 98-1246221
Entity Incorporation, State or Country Code UT
Entity Address, Address Line One 633 W. 5th Street
Entity Address, Address Line Two Suite 2826
Entity Address, City or Town Los Angeles
Entity Address, State or Province CA
Entity Address, Postal Zip Code 90071
City Area Code (888)
Local Phone Number 777-4362
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period true
XML 7 mcoa_8k-091422_htm.xml IDEA: XBRL DOCUMENT 0001078799 2022-09-12 2022-09-12 iso4217:USD shares iso4217:USD shares 0001078799 false 8-K 2022-09-12 MARIJUANA COMPANY OF AMERICA, INC. UT 000-27039 98-1246221 633 W. 5th Street Suite 2826 Los Angeles CA 90071 (888) 777-4362 false false false false true true EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 1 21 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover Cover Cover 1 false false All Reports Book All Reports mcoa_8k-091422.htm ex10x1.htm mcoa-20220912.xsd mcoa-20220912_lab.xml mcoa-20220912_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "mcoa_8k-091422.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "mcoa_8k-091422.htm" ] }, "labelLink": { "local": [ "mcoa-20220912_lab.xml" ] }, "presentationLink": { "local": [ "mcoa-20220912_pre.xml" ] }, "schema": { "local": [ "mcoa-20220912.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 21, "memberCustom": 0, "memberStandard": 0, "nsprefix": "MCOA", "nsuri": "http://wwwmedicalmarijuanacompanyofamerica.com/20220912", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "mcoa_8k-091422.htm", "contextRef": "From2022-09-12to2022-09-12", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "mcoa_8k-091422.htm", "contextRef": "From2022-09-12to2022-09-12", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://wwwmedicalmarijuanacompanyofamerica.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" } }, "version": "2.1" } ZIP 14 0001079973-22-001094-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001079973-22-001094-xbrl.zip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end